ESERLER

1. Uluslararası hakemli dergilerde yayımlanan makaleler:

A1. Z. Arat, S. Sezer, F.N. Ozdemir, M. Uyar, M. Turan, M. Haberal, “Predictors of hematopoietic response after renal transplantation.”, Tranplantation Proceedings, 35(7), 27162717, 2003

A2. O. Karacan, E. Tutal, M. Uyar, F.O. Eyüboğlu, S. Sezer, F.N. Ozdemir, “Pulmonary function in uremic patients on long-term hemodialysis.”, Renal Failure, 26(3), 273-278, 2004

A3. S. Sezer, M. Uyar, A. Akcay, Z. Arat, E. Kulah, F.N. Ozdemir, M. Haberal, “Endothelial nitric oxide synthase and angiotensin II type 1 receptor gene polymorphisms can influence chronic inflammatory state in renal transplant patients.”, Tranplantation Proceedings, 37(2), 776-778, 2005

A4. S. Sezer, F.N. Ozdemir, R. Elsurer, M. Uyar, Z. Arat, M. Haberal, “Pretransplantation and posttransplantation body mass indices and prognosis in renal transplant recipients: low versus normal.”, Transplantation Proceedings, 2994-2997, 2004

A5. S. Sezer, M. Uyar, Z. Arat, F.N. Ozdemir, M. Haberal, “Potential effects of 1,25dihydroxyvitamin D3 in renal transplant recipients.”, Transplantation Proceedings, 37(7),

3109-3111, 2005

A6. S. Sezer, A. Bilgiç, M. Uyar, Z. Arat, F.N. Ozdemir, M. Haberal, “Risk factors for development of posttransplant diabetes mellitus in renal transplant recipients.”, Transplantation Proceedings,  38(2), 529-532, 2006

A7. M. Uyar, S. Sezer, Z. Arat, R. Elsürer, F.N. Ozdemir, M. Haberal, “1,25dihydroxyvitamin D(3) therapy is protective for renal function and prevents hyperparathyroidism in renal allograft recipients.”, Transplantation Proceedings, 38(7) 20692073, 2006

A8. E. Kulah, S. Sezer, M. Uyar, Z. Arat, F.N. Ozdemir, “Effects of ACE gene polymorphism on vitamin D therapy according to parathyroid hormone level in patients on hemodialysis.”, Advances in Therapy, 23(5), 778-786, 2006

A9. B. Akman, M. Uyar, B. Afsar, S. Sezer, F.N. Ozdemir, M. Haberal, “Lipid profile during azathioprine or mycophenolate mofetil combinations with cyclosporine and steroids.”, Transplantation Proceedings , 39(1), 135-137, 2007

A10. H. Bozbas, I. Atar, A. Yildirir, A. Ozgul, M. Uyar, N. Ozdemir, H. Muderrisoglu, B. Ozin, “Prevalence and predictors of arrhythmia in end stage renal disease patients on hemodialysis.”, Renal Failure, 29(3), 331-339, 2007

A11. B. Akman, M. Uyar, B. Afsar, S. Sezer, F.N. Ozdemir, M. Haberal, “Adherence, depression and quality of life in patients on a renal transplantation waiting list.”, Transplant International, 20(8), 582-587, 2007

A12. S. Sahin, A. Gürkan, M. Uyar, H. Dheir, V. Turunç, C. Varilsuha, S. Kaçar, “Conversion to proliferation signal inhibitors-based immunosuppressive regimen in kidney transplantation: to whom and when?”, Transplantation Proceedings ,43(3), 837-840, 2011

A13. M. Uyar, S. Sahin, H. Dheir, A. Gurkan, “The influence of hepatitis B and C virus infections on patient and allograft outcomes in kidney transplantation.”, Transplantation Proceedings , 43(3), 850-852 , 2011

A14. H. Dheir, S. Sahin, M. Uyar, A. Gurkan, V. Turunc, S. Kacar, D. Bayirli Turan, G. Basdemir, “Intensive polyoma virus nephropathy treatment as a preferable approach for graft surveillance.”, Transplantation Proceedings, 43(3), 867-870, 2011

A15 M. Uyar, S. Sezer, FN. Ozdemir, E. Kulah, Z. Arat, FB. Atac, M. Haberal. “Endothelial nitric oxide synthase polymorphism influences renal allograft outcome.”, Clinical

Transplantation, 28(2), 223-8, 2014

A16. SF. Yalın, N. Eren , A. Sinangil, VT. Yilmaz, E. Tatar, AR. Ucar, M. Sevinc, Ö. Can, A.

Gurkan, N. Arik, E. Alisir, M. Uyar, M. Yasar, S. Gulcicek, M. Mese, H. Dheir, U. Cakir, Ş.

Köksal Cevher, K. Turkmen, B. Guven, D. Guven Taymez, B. Erkalma Senates,T. Ecder, H.

Kocak, A. Uslu, E. Demir, T. Basturk, MB. Ogutmen, C. Kinalp, B. Dursun , Z. Bicik

Bahcebasi, S.  Sipahi, F. Dede, M. Oruc, Y. Caliskan, A. Genc, YB. Yelken, MR. Altıparmak,

1. Turkmen, N. Seyahi. “Fabry Disease Prevalence in Renal Replacement Therapy in

Turkey.” Nephron, 142(1), 26-33, 2019

A17. O. Bozkurt, M. Uyar, ÜF.  Demir. “Determination of Health Anxiety Level in Living

Organ Donation.”, Transplantation Proceedings, 51(4), 1139-1142, 2019

A18. O. Bozkurt, B. Erdoğan, M. Uyar. “A Retrospective Evaluation of 728 Kidney Donors

Who Applied for Organ Donation.”, Transplantation Proceedings, 51(4), 1054-1057,2019

A19. ME. Demir, M. Uyar, O. Merhametsiz. “Combination of High-Dose Intravenous

Cyclosporine and Plasma Exchange Treatment Is Effective in Post-Transplant Recurrent

Focal Segmental Glomerulosclerosis: Results of Case Series.”, Transplantation Proceedings, 52(3), 843-849, 2020

A20. E. Demir, M. Uyar, E. Parmaksiz, A. Sinangil, B. Yelken, AB. Dirim, O. Merhametsiz , S. Yadigar, Z. Atan Ucar, AR. Ucar, ME. Demir, M. Mese, EB. Akin, N. Garayeva, S. Safak, QA. Oto, H. Yazici, A. Turkmen. “COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul.”,Transplant Infectious Disease, 22(5), e13371,2020

A21. M. Sevmis, ME  Demir, O Merhametsiz, S Aktas, S.Sevmis, M. Uyar. ”Grafts With

Multiple Renal Arteries in Kidney Transplantation”, Transplantation Proceedings, S00411345(20)32690-7, 2020

A22. M. Sevmis, S. Aktas, U. Alkara, H. Kilercik, M. Uyar, S. Sevmis. “Risk Factors,

Diagnosis, and Treatment of Lymphocele After Renal Transplantation: A Retrospective

Study.”,Transplantation Proceedings, S0041-1345(21)00032-4, 2021

A23. ME Demir, Ö. Merhametsiz, N. Yurttutan Uyar, M. Uyar, M. Sevmis, S. Sevmis, S.

Aktas, U. Payam Hacısalihoğlu, Z. Füsun Baba. “COVID19 Disease in a Kidney Transplant

Recipient With Diffuse Intrarenal Hemorrhage” . Experimental and Clinical Transplantation.

Epub

A24. Murat Sevmis , Sema Aktas , Utku Alkara , hakan Kilercik , HS Göksoy , Murathan

Uyar, Şinasi Sevmis. Sequential Liver, Kidney, and Autologous Stem Cell Transplant for AL

Amyloidosis: A Case Report. Transplant Proc. 2022 Jan-Feb;54(1):197-201

A25. Ozgur Akin Oto , Savas Ozturk , Mustafa Arici , Arzu Velioğlu , Belda Dursun , Nurana

Guller , İdris Şahin , Zeynep Ebru Eser , Saime Paydaş , Sinan Trabulus , Sümeyra Koyuncu ,

Murathan Uyar , Zeynep Ural , Rezzan Eren Sadioğlu, Hamad Dheir , Neriman Sıla Koç ,

Hakan Özer , Beyza Algül Durak , Cuma Bülent Gül , Umut Kasapoğlu , Ebru Gök Oğuz ,

Mehmet Tanrısev , Gülşah Şaşak Kuzgun , Safak Mirioglu , Erkan Dervişoğlu , Ertuğrul

Erken , Numan Görgülü , Sultan Özkurt , Zeki Aydın , İlhan Kurultak , Melike Betül

Öğütmen , Serkan Bakırdöğen , Burcu Kaya , Serhat Karadağ , Memnune Sena Ulu , Özkan

Güngör , Elif Arı Bakır , Ali Rıza Odabaş , Nurhan Seyahi , Alaattin Yıldız , Kenan Ateş Middle-term outcomes in renal transplant recipients with COVID-19: a national, multicenter, controlled study. Clin Kidney J. 2022 Feb 14;15(5):999-1006

A26. . Erol Demir , Zuhal Atan Ucar , Hamad Dheir , Ramazan Danis , Berna Yelken ,

Murathan Uyar , Ergun Parmaksiz , Ayse Serra Artan , Ayse Sinangil , Ozgur Merhametsiz ,

Serap Yadigar , Ahmet Burak Dirim8, Baris Akin , Nurana Garayeva , Seda Safak, Aydin

Turkmen . COVID-19 in Kidney Transplant Recipients: A Multicenter Experience from the

First Two Waves of Pandemic. BMC Nephrol. 2022 May 12;23(1):183

1. Uluslararası bilimsel toplantılarda sunulan ve bildiri kitaplarında (proceedings) basılan bildiriler:

B1. B. Akman, S. Sezer, F.N. Ozdemir, M. Uyar, B. Budak, A. Haberal, M. Haberal, “Effect of peritoneal transport status on lipid profile of CAPD patients “,  XXXIX Congress of the

European Renal Association – European Dialysis and Transplant Association, Nephrology

Dialysis Tranplantation, 17 (suppl. 12), A161,Copenhagen, Denmark, 2002

B2. U. Yakupoglu, F. N. Ozdemir, B. Akman, M. Uyar, A. Sezgin, S. Aslamaci, M. Haberal, “Evaluation of serum albumin levels in progress of acute renal failure after coronary artery bypass graft surgery”,  XXXIX Congress of the European Renal Association – European Dialysis and Transplant Association, Nephrology Dialysis Tranplantation, 17 (suppl. 12),

A89, Copenhagen, Denmark, 2002

B3. F. N. Ozdemir, M. Uyar, B. H. Ozdemir, S. Sezer, M. Haberal, “Cyclophosphamide and plasmapheresis therapy has a benefıcial effect on lupus nephritis”, World Congress of Nephrology, Berlin, Germany, 8-12 June 2003. (Jointly organised by the European Renal Association – European Dialysis & Transplant Association (ERA-EDTA) 40th Congress and the International Society of Nephrology (ISN) 17th Congress). Nephrology Dialysis

Transplantation, 18 (suppl. 4), 355, Berlin, Germany, 2003

B4. B. H. Ozdemir, F. N. Ozdemir, S. Sezer, M. Uyar, S. Boyacioglu, M. Haberal, “The influence of pre-transplant ifn-alpha therapy on interstıtıal fibrosis in renal allograft biopsies with hepatitis c virus infection”,  World Congress of Nephrology, (Jointly organised by the European Renal Association – European Dialysis & Transplant Association (ERA-EDTA)

40th Congress and the International Society of Nephrology (ISN) 17th Congress), Nephrology

Dialysis Transplantation, 18 (suppl. 4), 381, Berlin, Germany, 2003

B5. B. Akman, B. H. Ozdemir, B. Afşar, M. Uyar, Z. Arat, S. Sezer, F. N. Özdemir, M.

Haberal, “Effect of mycophenolate mofetil on renal allograft arteriosclerosis”, 3rd World

Congress of Nephrology, Nephrology, 10, A209, Singapore, 2005

B6. S. Sezer, M. Uyar, B. Akman, B.H. Ozdemir, F.N. Ozdemir, “Immunosuppressive therapy has beneficial effect in the course of idiopathic membranoproliferative glomerulonephritis”,. 5th International Symposium on Urology, Nephrology and

Transplantation of SIUT, CAST-SIUT Proceedings, 262, Karachi, Pakistan, 2005

B7. M. Uyar, S. Sezer, Z. Arat, R. Elsürer, F.N. Ozdemir, M. Haberal, “1,25-dihidroxyvitamin D(3) therapy is protective for renal function and prevent hyperparathyroidism in renal allograft recipients”, 9th Congress of Asian Society of Transplantation, CAST-SIUT Proceedings, 43, Karachi, Pakistan, 2005

B8. M. Uyar, S. Sezer, Z. Arat, FN. Ozdemir. “ Serum ghrelin levels in patients receiving renal replacement therapy.”, 43^rd Congress of the European Renal Association – European Dialysis and Transplant Association, Nephrology Dialysis Tranplantation, 21, supp4, iv448iv459, Glasgow, 2006

B9. BH. Ozdemir, FN. Ozdemir, R. Elsürer Afsar, M. Uyar, M. Haberal. “Influence of 1 25 dihydroxyvitamin D3 on HLA DR expression macrophage infiltration and graft survival in renal allografts”, World Transplant Congress, AJT, 6, S2, 199,  Boston, 2006

1. Yazılan ulusal/uluslararası kitaplar veya kitaplardaki bölümler::

C1. Yazılan ulusal/uluslararası kitaplar:

C1.1. Kalp Nakli. Editörler: Dr Mehmet Balkanay, Dr Denyan Mansuroğlu

Eşzamanlı Kalp-Böbrek Nakli: 249

2. Yazılan ulusal/uluslararası kitaplardaki bölümler:

C2.1. Wahington manuel. Nephrology 4th Edition.   

Asit-Baz bozuklukları:  74

Akut Böbrek Hasarlı hastaya yaklaşım: 88

1. Ulusal hakemli dergilerde yayımlanan makaleler:

D1. İ. Atar, N. D. Konaş, M. Uyar, A. Atar, H. Bozbaş, Ö. Gülmez, S. Sezer, N. Özdemir, H. Müderrisoğlu, B. Özin., “P-wave dispersion in patients with chronic renal failure and paroxysmal atrial fibrillation.”, Turkish Journal of Arrhythmia, Pacemaker and Electrophysiology (TAPE) , 45-52 pp., 2007

D2. M. Uyar, S. Sezer, Z. Arat, M. Haberal, S. Ertek, FN Özdemir. “The Relationship of

Plasma Ghrelin Levels with Malnutrition in Patients on Peritoneal Dialysis and

Haemodialysis.”, Turkey Clinics J Nephrol., 8(2), 39-46, 2013

D3. ME Demir, Ö. Merhametsiz, M. Uyar, M. Sevmis, S. Aktas, S. Sevmiş.” Does Diltiazem

Provide Benefits on Allograft Functions in Kidney Transplant Recipients?”, Journal of Harran

University Medical Faculty,17(3), 425-430, 2020

D4. ME Demir, M. Uyar, Ö. Merhametsiz, M. Sevmis, S. Aktas, S. Sevmis. “Outcomes of mTORi-involving minimized immunosuppression protocols in renal transplantation.” Journal of Health Sciences and Medicine, 4(1), 71-77, 2021

1. Ulusal bilimsel toplantılarda sunulan ve bildiri kitaplarında basılan bildiriler::

E1. S. Şahin, M. Uyar, S. Aktaş, Ş. Sevmiş, H. Karakayalı. “Donor type does not affect the likelihood of recurrence in posttransplant FSGS relapse.” 30. National Nephrology, Hypertension, Dialysis and Transplantation Congress, Turkish Journal of Nephrology,

Dialysis and Transplantation, 22(3), p112-13, 2013

E2. M. Uyar, S. Şahin, Ş.Sevmiş, S. Aktaş, H. Karakayalı, “Risk Factors Affecting Graft

Survival”, 30. National Congress of Nephrology, Hypertension, Dialysis and Transplantation,

Turkish Journal of Nephrology, Dialysis and Transplantation, 22(3), s105, 2013

E3. S. Şahin, M. Uyar, S. Aktaş, Ş. Sevmiş, H. Karakayalı, “Efficacy of Preemptive

Plasmapheresis in Prevention of FSGS Recurrence After Kidney Transplantation”, 30th

National Congress of Nephrology, Hypertension, Dialysis and Transplantation, Turkish

Journal of Nephrology, Dialysis and Transplantation, 22(3), p113, 2013

E4. M. Uyar, S. Şahin, Ş.Sevmiş, S. Aktaş, H. Karakayalı, “Evaluation of Kidney Transplant

Patients: Results of a Single Centre.”, 30. National Congress of Nephrology, Hypertension,

Dialysis and Transplantation, Turkish Journal of Nephrology, Dialysis and Transplantation, 22(3), p148,, 2013

E5. S. Şahin, M. Uyar, O. Anık, S. Aktaş, Ş. Sevmiş, H. Karakayalı, “Reasons for Donor

Rejection in Live Donor Transplantation Preparation”, 30. National Congress of Nephrology,

Hypertension, Dialysis and Transplantation, Turkish Journal of Nephrology, Dialysis and

Transplantation, 22(3), p149,, 2013

E6. M. Uyar, S. Şahin, Ş.Sevmiş, S. Aktaş, H. Karakayalı,” Alternative Treatment in ABO

Incompatible and Cross Match Positive Patients: Cross Transplant”, 30. National Congress of

Nephrology, Hypertension, Dialysis and Transplantation, Turkish Journal of Nephrology,

Dialysis and Transplantation, 22(3), p149,, 2013

E7. M. Uyar, S. Şahin, Ş.Sevmiş, S. Aktaş, H. Karakayalı, “Risk Factors Affecting the

Development of Posttransplant Diabetes Mellitus”, 30. National Congress of Nephrology,

Hypertension, Dialysis and Transplantation, Turkish Journal of Nephrology, Dialysis and

Transplantation, 22(3), p149,, 2013

E8. K. Şerefhanoğulları, D. Turan Bayırlı, G. Yılmaz, M. Uyar, Ö. Özgün, G. Dayan.” Evaluation of the efficacy of ertapenem in bloodstream infections caused by gram negative bacteria in renal transplant patients”, XIX. Turkish Congress of Clinical Microbiology and Infectious Diseases, 297, Antalya, 2018

E9. M. Sevmis, ME Demir, Ö, Merhametsiz, M. Uyar, S. Aktas, S. Sevmis. “Does obesity prevent being a kidney donor? The Big Centre Experience”. 4. Hypertension dialysis and transplantation congress. Clinical series nephrology, dialysis and hypertension, 1(5), 2020